Investigators: Jonathan Carapetis, Rebecca Trowman
Funded by a 5-year NHMRC Investigator grant to implement a strategy to eliminate rheumatic heart disease (RHD) as a public health problem in Australia.
This research aims to:
- Reduce the incidence of Group A Streptococcal (GAS) infection in Australia via two complementary primary prevention approaches:
- Environmental health interventions; and
- Developing and evaluating a safe, effective and affordable vaccine against GAS
- Improve accuracy in diagnosing acute rheumatic fever (ARF)
- Reduce the incidence of recurrent ARF by developing a long acting penicillin implant.